Abstract
We carried out a genome-wide association study of breast cancer predisposition with replication and refinement studies involving 6,145 cases and 33,016 controls and identified two SNPs (rs4415084 and rs10941679) on 5p12 that confer risk, preferentially for estrogen receptor (ER)-positive tumors (OR = 1.27, P = 2.5 × 10−12 for rs10941679). The nearest gene, MRPS30, was previously implicated in apoptosis, ER-positive tumors and favorable prognosis. A recently reported signal in FGFR2 was also found to associate specifically with ER-positive breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pharoah, P.D. et al. Nat. Genet. 31, 33–36 (2002).
Hunter, D.J. et al. Nat. Genet. 39, 870–874 (2007).
Stacey, S.N. et al. Nat. Genet. 39, 865–869 (2007).
Easton, D.F. et al. Nature 447, 1087–1093 (2007).
Kutyavin, I.V. et al. Nucleic Acids Res. 34, e128 (2006).
Huijts, P.E. et al. Breast Cancer Res. 9, R78 (2007).
Theodorou, V. et al. Oncogene 23, 6047–6055 (2004).
McVean, G.A. et al. Science 304, 581–584 (2004).
Cavdar Koc, E. et al. FEBS Lett. 492, 166–170 (2001).
Sun, L. et al. Gene 208, 157–166 (1998).
Cavdar Koc, E., Burkhart, W., Blackburn, K., Moseley, A. & Spremulli, L.L. J. Biol. Chem. 276, 19363–19374 (2001).
Grigoriadis, A. et al. Breast Cancer Res. 8, R56 (2006).
van't Veer, L.J. et al. Nature 415, 530–536 (2002).
Yu, K., Ganesan, K., Miller, L.D. & Tan, P. Clin. Cancer Res. 12, 3288–3296 (2006).
Acknowledgements
We thank G.H. Olafsdottir for assistance in the ascertainment of individuals with breast cancer. This project was funded in part by contract number 018827 (POLYGENE) from the 6th Framework Programme of the European Union (to S.N.S., T.R. and L.A.K.), the Swedish Cancer Society, the Gustav V Jubilee Foundation, the Bert von Kantzow Foundation and the Nilsson-Ehle Foundation (to A.L. and S.M.) and the US National Cancer Institute (grant CA-RO1 89085-01A to O.I.O).
Author information
Authors and Affiliations
Contributions
The study was designed by S.N.S., A.M., T. Jonsson, K.K., L.A.K., J.R.G., T.R., U.T., O.T.J., A.K. and K.S. Patient ascertainment, recruitment and medical record review was organized and carried out by S.N.S., S.T., K.K.A., L.J.S., D.W.S., K.C.A.v.E., B.E.H., L.N.K., L.Le.M., E.M., R.A., B.S., J.L., J. Godino, E.P., A.T., S.P., J.R., S.M., H.S., T. Jonsdottir, J.H., J.J., T.S., G. Myrdal, H.N.G., T. Jonsson, L.G., K.K., S.G.S., K.A., J.D.F., C.A., T.O., O.I.O., C.A.H., A.L., J.I.M., L.A.K. and O.T.J. Biological material collection and handling was supervised by S.N.S., K.K., J.I.M., S.G.S, O.I.O., L.A.K., J.S. and U.T. Genotyping was supervised by S.N.S., M.J., A.S., J.K. and U.T. Statistical analysis was carried out by A.M., P.S., G.F.J., J.T.B., J. Gudmundsson and A.K. Bioinformatic analysis was carried out by S.N.S., S.A.G. and G. Masson. S.N.S. and A.M. drafted the manuscript with substantial contributions from P.S., U.T., O.T.J., A.K. and K.S. All authors contributed to the final version of the paper. Principal collaborators for the patient cohorts were O.T.J. (Iceland), L.A.K. (Holland), J.I.M. (Spain), A.L. (Sweden), O.I.O. (Nigeria) and C.A.H. (Multiethnic Cohort, USA).
Corresponding authors
Ethics declarations
Competing interests
Authors whose affiliations are listed as deCODE Genetics are shareholders and/or employees of deCODE Genetics, a biotechnology company.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Figure 1 and Supplementary Tables 1–7 (PDF 286 kb)
Rights and permissions
About this article
Cite this article
Stacey, S., Manolescu, A., Sulem, P. et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer. Nat Genet 40, 703–706 (2008). https://doi.org/10.1038/ng.131
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.131
This article is cited by
-
The genomic and transcriptome characteristics of lung adenocarcinoma patients with previous breast cancer
BMC Cancer (2022)
-
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Breast Cancer Research (2021)
-
Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer
Scientific Reports (2020)
-
Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer
Journal of Genetics (2020)
-
Polygenic Risk Scores in Breast Cancer
Current Breast Cancer Reports (2019)
